Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The complement system in prion diseases.

Neil A Mabbott1

  • 1Institute for Animal Health, Neuropathogenesis Unit, Ogston Building, West Mains Road, Edinburgh EH9 3JF, UK. neil.mabbott@bbsrc.ac.uk

Current Opinion in Immunology
|September 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genome sequence of the nematode <i>Ostertagia ostertagi</i> (Stiles, 1892) (Rhabditida, Trichostrongylidae).

Wellcome open research·2026
Same author

TREM2 supports neuronal protection and microglial reactivity without an effect on misfolded protein deposition in chronic neurodegenerative prion disease.

Frontiers in neuroscience·2025
Same author

Non-neuronal brain biology and its relevance to animal welfare.

Neuroscience and biobehavioral reviews·2025
Same author

Acute LPS exposure enhances susceptibility to peripheral prion infection.

Scientific reports·2025
Same author

Systematic review and meta-analysis of COVID-19 mRNA vaccine effectiveness against hospitalizations in adults.

Immunotherapy advances·2024
Same author

The effect of a dominant kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy on brain development and neuropathology.

Neurobiology of disease·2024
Same journal

A blind spot of human T cell immunology: epitope specificity in secondary lymphoid organs.

Current opinion in immunology·2026
Same journal

Germinal center responses at barrier organ sites.

Current opinion in immunology·2026
Same journal

Ocular sarcoidosis: from clinical signs to targeted interventions.

Current opinion in immunology·2026
Same journal

On or within: spatial determinants of antigen handling in the nasal turbinates.

Current opinion in immunology·2026
Same journal

Decoding the complexity of intestinal immunity with spatial transcriptomics.

Current opinion in immunology·2026
Same journal

Reconsidering the immunological aspects of solid-phase assays for antiphospholipid antibodies detection.

Current opinion in immunology·2026
See all related articles

The complement system, crucial for innate immunity, may be exploited by prion diseases (TSEs) to infect cells. Further research is needed to determine if complement inhibitors can treat these neurodegenerative disorders.

Area of Science:

  • Immunology
  • Neuroscience
  • Pathology

Background:

  • The complement system is vital for innate immunity, identifying and eliminating pathogens.
  • Some pathogens manipulate the complement system for their benefit.
  • Transmissible spongiform encephalopathies (TSEs), or prion diseases, appear to leverage complement for infection in lymphoid tissues.

Purpose of the Study:

  • To investigate the role of the complement system in prion disease pathogenesis.
  • To explore how TSEs interact with and potentially utilize the complement system.
  • To assess the potential of complement inhibitors as a therapeutic strategy for TSEs.

Main Methods:

  • Review of existing literature on complement system function and TSE pathology.
  • Analysis of studies detecting complement components in TSE-affected brains.

Related Experiment Videos

  • Discussion of the implications of complement dysregulation in neurodegeneration.

    • Main Results:

    • The complement system, while protective, can be subverted by pathogens.
    • Evidence suggests TSEs utilize the complement system to facilitate infection in lymphoid tissues.
    • Active complement components are found in the brains of TSE hosts, indicating involvement in disease progression.

    Conclusions:

    • The complement system plays a complex role in prion diseases.
    • Unregulated complement activation may contribute to neurodegeneration observed in TSEs.
    • The therapeutic potential of complement inhibitors for TSEs requires further investigation.